Nanjing Medical University; Nanjing Medical University Affiliated Cancer Hospital; Key Laboratory of Human Functional Genomics of Jiangsu Province

2 ARTICLES PUBLISHED IN JoVE

Medicine

A Repetitive Concussive Head Injury Model in Mice

Zhihui Yang^1,2, Fan Lin^1,2, Amanda S. Weissman^1,2, Emily Jaalouk^1,2, Qing-shan Xue³, Kevin K.W. Wang^1,2

¹Program for Neurotrauma, Neuroproteomics & Biomarkers Research, University of Florida, ²Department of Psychiatry, University of Florida, ³Department of Neuroscience, University of Florida

Concussion presents the most common type of traumatic brain injury. Therefore, a repetitive concussive animal model, which replicates the important features of an injury in patients, may provide a means to study concussion in a rigorous, controlled, and efficient manner.

Cancer Research

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Ziyi Hu^*1, Tingting Zhou^*1, Fangrong Wu¹, Fan Lin^1,2

¹Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, ²Institute for Brain Tumors & Key Laboratory of Rare Metabolic Diseases, Nanjing Medical University; Nanjing Medical University Affiliated Cancer Hospital; Key Laboratory of Human Functional Genomics of Jiangsu Province

The glioma stem cells (GSCs) are a small fraction of cancer cells which play essential roles in tumor initiation, angiogenesis, and drug resistance in glioblastoma (GBM), the most prevalent and devastating primary brain tumor. The presence of GSCs makes the GBM very refractory to most of individual targeted agents, so high-throughput screening methods are required to identify potential effective combination therapeutics. The protocol describes a simple workflow to enable rapid screening for potential combination therapy with synergistic interaction. The general steps of this workflow consist of establishing luciferase-tagged GSCs, preparing matrigel coated plates, combination drug screening, analyzing, and validating the results.